ANI Pharma (ANIP) Tops Q2 EPS by 16c, Updates Guidance
ANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $1.44, $0.16 better than the analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
